Post-transcriptional dysregulation in autism, schizophrenia, and bipolar disorder

Abstract

The alteration of gene expression is not restricted to transcriptional regulation but includes a variety of post-transcriptional mechanisms; however, the role of the latter in many diseases remains relatively unknown. By using an RNA-Seq dataset of 1510 brain samples from individuals with autism spectrum disorder (ASD), bipolar disorder (BD), schizophrenia (SCZ), and controls, we assessed the contribution of post-transcriptional dysregulation and identified top perturbators accountable for transcriptomic alterations in neuropsychiatric disorders. Approximately 30% of the expression variability was attributed to post-transcriptional dysregulation. Interestingly, mature mRNA levels tended to be post-transcriptionally downregulated in SCZ and BD, leading to the inhibition of neurogenesis and neural differentiation, while they were upregulated in ASD, resulting in enhanced activity of apoptosis. These findings imply contrasting pathologies involving RNA metabolism across neuropsychiatric disorders. An RNA-binding protein, ELAVL3, was predicted to be significantly involved in the disruption of post-transcriptional regulation in all three disorders. To validate this, we knocked down its expression in cerebral organoids. Not only did the differentially expressed genes in ELAVL3 knockdown cover a considerable proportion of predicted targets in the three disorders, but we also found that neurogenesis was significantly affected, given the diminished proliferation and consequently reduced size of the organoids. The present study extends the current understanding of the link between post-transcriptional regulation and neuropsychiatric disorders and provides new potential therapeutic targets for early intervention.

Keywords

post-transcriptional gene regulation / psychiatric disorders / RNA-binding protein / ELAVL3

Fundings

This work received no funding from any source.

Acknowledgments

We appreciate comments from the editor and anonymous reviewers.

References

[1] Horwitz T, Lam K, Chen Y, et al. A decade in psychiatric GWAS research[J]. Mol Psychiatry, 2019, 24(3): 378-389. doi: 10.1038/s41380-018-0055-z

[2] Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci[J]. Nature, 2014, 511(7510): 421-427. doi: 10.1038/nature13595

[3] Wang Y, Liu L, Lin M. Psychiatric risk gene transcription factor 4 preferentially regulates cortical interneuron neurogenesis during early brain development[J]. J Biomed Res, 2022, 36(4): 242-254. doi: 10.7555/JBR.36.20220074

[4] Wang P, Lin M, Pedrosa E, et al. CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment[J]. Mol Autism, 2015, 6: 55. doi: 10.1186/s13229-015-0048-6

[5] Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins[J]. Nat Rev Genet, 2014, 15(12): 829-845. doi: 10.1038/nrg3813

[6] Jungkamp AC, Stoeckius M, Mecenas D, et al. In vivo and transcriptome-wide identification of RNA binding protein target sites[J]. Mol Cell, 2011, 44(5): 828-840. doi: 10.1016/j.molcel.2011.11.009

[7] Keene JD. RNA regulons: Coordination of post-transcriptional events[J]. Nat Rev Genet, 2007, 8(7): 533-543. doi: 10.1038/nrg2111

[8] Gaidatzis D, Burger L, Florescu M, et al. Analysis of intronic and exonic reads in RNA-seq data characterizes transcriptional and post-transcriptional regulation[J]. Nat Biotechnol, 2015, 33(7): 722-729. doi: 10.1038/nbt.3269

[9] La Manno G, Soldatov R, Zeisel A, et al. RNA velocity of single cells[J]. Nature, 2018, 560(7719): 494-498. doi: 10.1038/s41586-018-0414-6

[10] Alkallas R, Fish L, Goodarzi H, et al. Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's disease[J]. Nat Commun, 2017, 8(1): 909. doi: 10.1038/s41467-017-00867-z

[11] Akbarian S, Liu C, Knowles JA, et al. The PsychENCODE project[J]. Nat Neurosci, 2015, 18(12): 1707-1712. doi: 10.1038/nn.4156

[12] Liao Y, Smyth GK, Shi W. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features[J]. Bioinformatics, 2014, 30(7): 923-930. doi: 10.1093/bioinformatics/btt656

[13] Josse J, Husson F. missMDA: A package for handling missing values in multivariate data analysis[J]. J Stat Soft, 2016, 70(1): 1-31. doi: 10.18637/jss.v070.i01

[14] Milborrow S, Hastie T, Tibshirani R. Earth: Multivariate adaptive regression splines[EB/OL]. [2024-04-01]. https://cran.r-project.org/src/contrib/Archive/earth/.

[15] Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Res, 2015, 43(7): e47. doi: 10.1093/nar/gkv007

[16] Robinson MD, McCarthy DJ, Smyth GK. EdgeR: A Bioconductor package for differential expression analysis of digital gene expression data[J]. Bioinformatics, 2010, 26(1): 139-140. doi: 10.1093/bioinformatics/btp616

[17] Suk HW, West SG, Fine KL, et al. Nonlinear growth curve modeling using penalized spline models: A gentle introduction[J]. Psychol Methods, 2019, 24(3): 269-290. doi: 10.1037/met0000193

[18] Topol A, Zhu S, Hartley BJ, et al. Dysregulation of miRNA-9 in a subset of schizophrenia patient-derived neural progenitor cells[J]. Cell Rep, 2016, 15(5): 1024-1036. doi: 10.1016/j.celrep.2016.03.090

[19] Dobin A, Davis CA, Schlesinger F, et al. STAR: Ultrafast universal RNA-seq aligner[J]. Bioinformatics, 2013, 29(1): 15-21. doi: 10.1093/bioinformatics/bts635

[20] Lambert SA, Albu M, Hughes TR, et al. Motif comparison based on similarity of binding affinity profiles[J]. Bioinformatics, 2016, 32(22): 3504-3506. doi: 10.1093/bioinformatics/btw489

[21] Kim D, Paggi JM, Park C, et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype[J]. Nat Biotechnol, 2019, 37(8): 907-915. doi: 10.1038/s41587-019-0201-4

[22] Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. Genome Biol, 2014, 15(12): 550. doi: 10.1186/s13059-014-0550-8

[23] Yu G, Wang L, Han Y, et al. ClusterProfiler: An R package for comparing biological themes among gene clusters[J]. OMICS: J Integr Biol, 2012, 16(5): 284-287. doi: 10.1089/omi.2011.0118

[24] Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J]. Nat Commun, 2019, 10(1): 1523. doi: 10.1038/s41467-019-09234-6

[25] Fromer M, Pocklington AJ, Kavanagh DH, et al. De novo mutations in schizophrenia implicate synaptic networks[J]. Nature, 2014, 506(7487): 179-184. doi: 10.1038/nature12929

[26] Gulsuner S, Walsh T, Watts AC, et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network[J]. Cell, 2013, 154(3): 518-529. doi: 10.1016/j.cell.2013.06.049

[27] Li M, Santpere G, Imamura Kawasawa Y, et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks[J]. Science, 2018, 362(6420): eaat7615. doi: 10.1126/science.aat7615

[28] Bailey TL, Johnson J, Grant CE, et al. The MEME suite[J]. Nucleic Acids Res, 2015, 43(W1): W39-W49. doi: 10.1093/nar/gkv416

[29] García-Mauriño SM, Rivero-Rodríguez F, Velázquez-Cruz A, et al. RNA binding protein regulation and cross-talk in the control of AU-rich mRNA fate[J]. Front Mol Biosci, 2017, 4: 71. doi: 10.3389/fmolb.2017.00071

[30] El Fatimy R, Davidovic L, Tremblay S, et al. Tracking the fragile X mental retardation protein in a highly ordered neuronal ribonucleoparticles population: A link between stalled polyribosomes and RNA granules[J]. PLoS Genet, 2016, 12(7): e1006192. doi: 10.1371/journal.pgen.1006192

[31] Åberg K, Saetre P, Lindholm E, et al. Human QKI, a new candidate gene for schizophrenia involved in myelination[J]. Am J Med Genet B Neuropsychiatr Genet, 2006, 141B(1): 84-90. doi: 10.1002/ajmg.b.30243

[32] Ince-Dunn G, Okano HJ, Jensen KB, et al. Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability[J]. Neuron, 2012, 75(6): 1067-1080. doi: 10.1016/j.neuron.2012.07.009

[33] Samuels TJ, Järvelin AI, Ish-Horowicz D, et al. Imp/IGF2BP levels modulate individual neural stem cell growth and division through myc mRNA stability[J]. elife, 2020, 9: e51529. doi: 10.7554/eLife.51529

[34] Ray D, Kazan H, Cook KB, et al. A compendium of RNA-binding motifs for decoding gene regulation[J]. Nature, 2013, 499(7457): 172-177. doi: 10.1038/nature12311

[35] Shu H, Donnard E, Liu B, et al. FMRP links optimal codons to mRNA stability in neurons[J]. Proc Natl Acad Sci U S A, 2020, 117(48): 30400-30411. doi: 10.1073/pnas.2009161117

[36] Lancaster MA, Knoblich JA. Generation of cerebral organoids from human pluripotent stem cells[J]. Nat Protoc, 2014, 9(10): 2329-2340. doi: 10.1038/nprot.2014.158

[37] Alural B, Genc S, Haggarty SJ. Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2017, 73: 87-103. doi: 10.1016/j.pnpbp.2016.03.010

[38] Aartsma-Rus A. New momentum for the field of oligonucleotide therapeutics[J]. Mol Ther, 2016, 24(2): 193-194. doi: 10.1038/mt.2016.14

[39] Owen MJ, O'Donovan MC. Schizophrenia and the neurodevelopmental continuum: Evidence from genomics[J]. World Psychiatry, 2017, 16(3): 227-235. doi: 10.1002/wps.20440

[40] Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis[J]. Lancet, 2013, 381(9875): 1371-1379. doi: 10.1016/S0140-6736(12)62129-1

[41] Chan JN, Sanchez-Vidana DI, Anoopkumar-Dukie S, et al. RNA-binding protein signaling in adult neurogenesis[J]. Front Cell Dev Biol, 2022, 10: 982549.

[42] Romero C, Werme J, Jansen PR, et al. Exploring the genetic overlap between twelve psychiatric disorders[J]. Nat Genet, 2022, 54(12): 1795-1802. doi: 10.1038/s41588-022-01245-2

[43] Cross-Disorder Group of the Psychiatric Genomics Consortium. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders[J]. Cell, 2019, 179(7): 1469-1482.e11. doi: 10.1016/j.cell.2019.11.020

[44] Lee JA, Damianov A, Lin CH, et al. Cytoplasmic Rbfox1 regulates the expression of synaptic and autism-related genes[J]. Neuron, 2016, 89(1): 113-28. doi: 10.1016/j.neuron.2015.11.025

[45] Dong D, Zielke HR, Yeh D, et al. Cellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder[J]. Autism Res, 2018, 11(7): 1076-1090. doi: 10.1002/aur.1966

[46] Sokol DK, Lahiri DK. Neurodevelopmental disorders and microcephaly: How apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly[J]. Front Mol Neurosci, 2023, 16: 1201723. doi: 10.3389/fnmol.2023.1201723

[47] Yan Z, Rein B. Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: Pathophysiological implications[J]. Mol Psychiatry, 2022, 27(1): 445-465. doi: 10.1038/s41380-021-01092-3

[48] Mulligan MR, Bicknell LS. The molecular genetics of nELAVL in brain development and disease[J]. Eur J Hum Genet, 2023, 31(11): 1209-1217. doi: 10.1038/s41431-023-01456-z

[49] Grassi E, Santoro R, Umbach A, et al. Choice of alternative polyadenylation sites, mediated by the RNA-binding protein Elavl3, plays a role in differentiation of inhibitory neuronal progenitors[J]. Front Cell Neurosci, 2019, 12: 518. doi: 10.3389/fncel.2018.00518

[50] Iossifov I, O'Roak BJ, Sanders SJ, et al. The contribution of de novo coding mutations to autism spectrum disorder[J]. Nature, 2014, 515(7526): 216-221. doi: 10.1038/nature13908

[51] Ogawa Y, Kakumoto K, Yoshida T, et al. Elavl3 is essential for the maintenance of Purkinje neuron axons[J]. Sci Rep, 2018, 8(1): 2722. doi: 10.1038/s41598-018-21130-5

[52] Sawada T, Chater TE, Sasagawa Y, et al. Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids[J]. Mol Psychiatry, 2020, 25(11): 2695-2711. doi: 10.1038/s41380-020-0844-z

[53] Chen G, Yu B, Tan S, et al. GIGYF1 disruption associates with autism and impaired IGF-1R signaling[J]. J Clin Invest, 2022, 132(19): e159806. doi: 10.1172/JCI159806

[54] Brent BK, Thermenos HW, Keshavan MS, et al. Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: A review of structural MRI findings[J]. Child Adolesc Psychiatr Clin N Am, 2013, 22(4): 689-714. doi: 10.1016/j.chc.2013.06.003